Detalhe da pesquisa
1.
Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f.
Int J Cancer
; 136(7): 1579-88, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25137037
2.
Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions.
Int J Cancer
; 128(10): 2296-305, 2011 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20669225
3.
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.
BMC Cancer
; 11: 33, 2011 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21266077
4.
The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro.
Cancer Lett
; 364(2): 142-55, 2015 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25960282
5.
Loss of chromosome 1p/19q in oligodendroglial tumors: refinement of chromosomal critical regions and evaluation of internexin immunostaining as a surrogate marker.
J Neuropathol Exp Neurol
; 70(3): 177-82, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21293300
6.
Chromosomal and microRNA expression patterns reveal biologically distinct subgroups of 11q- neuroblastoma.
Clin Cancer Res
; 16(11): 2971-8, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20406844
7.
Global MYCN transcription factor binding analysis in neuroblastoma reveals association with distinct E-box motifs and regions of DNA hypermethylation.
PLoS One
; 4(12): e8154, 2009 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19997598
8.
Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival.
PLoS One
; 4(11): e7850, 2009 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19924232